Ansun Biopharma — a San Diego biotech with a drug for respiratory infections caused by influenza and parainfluenza — has raised an $80 million Series B round...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129